Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NARF mRNA] | CTD | PMID:31150632 | (1->4)-beta-D-glucan | multiple interactions | ISO | Narf (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NARF mRNA | CTD | PMID:36331819 | 1,2-dichloroethane | decreases expression | ISO | Narf (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of NARF mRNA | CTD | PMID:28189721 and PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | Narf (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of NARF mRNA | CTD | PMID:22206623 | 17beta-estradiol | increases expression | ISO | NARF (Homo sapiens) | 6480464 | Estradiol results in increased expression of NARF mRNA | CTD | PMID:23019147 | 17beta-estradiol | multiple interactions | ISO | NARF (Homo sapiens) | 6480464 | [Estradiol co-treated with Norethindrone Acetate] results in increased expression of NARF mRNA | CTD | PMID:22217510 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of NARF mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Narf (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NARF mRNA | CTD | PMID:19770486 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NARF mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NARF mRNA | CTD | PMID:21215274 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of NARF mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of NARF mRNA | CTD | PMID:21346803 | 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | Narf (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:19467301 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | Narf (Mus musculus) | 6480464 | tetrabromobisphenol A results in decreased expression of NARF mRNA | CTD | PMID:25172293 | 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of NARF mRNA | CTD | PMID:30723492 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Narf (Mus musculus) | 6480464 | Fenretinide results in decreased expression of NARF mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of NARF mRNA | CTD | PMID:30047161 | all-trans-retinoic acid | increases expression | ISO | NARF (Homo sapiens) | 6480464 | Tretinoin results in increased expression of NARF mRNA | CTD | PMID:33167477 | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of NARF mRNA | CTD | PMID:30047161 | benzene | increases expression | ISO | NARF (Homo sapiens) | 6480464 | Benzene results in increased expression of NARF mRNA | CTD | PMID:19162166 | benzo[a]pyrene | increases methylation | ISO | NARF (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of NARF promoter | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | NARF (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of NARF intron | CTD | PMID:30157460 | benzo[e]pyrene | increases methylation | ISO | NARF (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of NARF intron | CTD | PMID:30157460 | bisphenol A | increases expression | ISO | NARF (Homo sapiens) | 6480464 | bisphenol A results in increased expression of NARF mRNA | CTD | PMID:23019147 | bisphenol A | affects expression | ISO | NARF (Homo sapiens) | 6480464 | bisphenol A affects the expression of NARF mRNA | CTD | PMID:30903817 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of NARF mRNA | CTD | PMID:30816183 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of NARF gene | CTD | PMID:28505145 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of NARF mRNA | CTD | PMID:25181051 and PMID:32145629 | carbamazepine | affects expression | ISO | NARF (Homo sapiens) | 6480464 | Carbamazepine affects the expression of NARF mRNA | CTD | PMID:25979313 | carbon nanotube | decreases expression | ISO | Narf (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of NARF mRNA | CTD | PMID:25620056 | choline | multiple interactions | ISO | Narf (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NARF mRNA | CTD | PMID:20938992 | chromium(6+) | affects expression | ISO | Narf (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of NARF mRNA | CTD | PMID:28472532 | cisplatin | multiple interactions | ISO | NARF (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of NARF mRNA | CTD | PMID:27392435 | cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of NARF mRNA | CTD | PMID:20187946 | copper(II) sulfate | increases expression | ISO | NARF (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of NARF mRNA | CTD | PMID:19549813 | cyclosporin A | decreases expression | ISO | Narf (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of NARF mRNA | CTD | PMID:19770486 | cyclosporin A | decreases expression | ISO | NARF (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of NARF mRNA | CTD | PMID:25562108 | dibenz[a,h]anthracene | increases expression | ISO | Narf (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | doxorubicin | decreases expression | ISO | NARF (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of NARF mRNA | CTD | PMID:29803840 | epoxiconazole | decreases expression | ISO | Narf (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of NARF mRNA | CTD | PMID:35436446 | fenamidone | decreases expression | ISO | Narf (Mus musculus) | 6480464 | fenamidone results in decreased expression of NARF mRNA | CTD | PMID:27029645 | fluoranthene | multiple interactions | ISO | Narf (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of NARF mRNA | CTD | PMID:28329830 | folic acid | multiple interactions | ISO | Narf (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NARF mRNA | CTD | PMID:20938992 | gallic acid | increases expression | ISO | NARF (Homo sapiens) | 6480464 | Gallic Acid results in increased expression of NARF mRNA | CTD | PMID:34408198 | genistein | increases expression | ISO | NARF (Homo sapiens) | 6480464 | Genistein results in increased expression of NARF mRNA | CTD | PMID:23019147 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of NARF mRNA | CTD | PMID:33387578 | inulin | multiple interactions | ISO | Narf (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NARF mRNA | CTD | PMID:36331819 | L-methionine | multiple interactions | ISO | Narf (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of NARF mRNA | CTD | PMID:20938992 | lead diacetate | increases expression | ISO | Narf (Mus musculus) | 6480464 | lead acetate results in increased expression of NARF mRNA | CTD | PMID:22609695 | leflunomide | decreases expression | ISO | NARF (Homo sapiens) | 6480464 | leflunomide results in decreased expression of NARF mRNA | CTD | PMID:28988120 | methapyrilene | increases methylation | ISO | NARF (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of NARF intron | CTD | PMID:30157460 | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of NARF mRNA | CTD | PMID:30047161 | methyl methanesulfonate | increases expression | ISO | NARF (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of NARF mRNA | CTD | PMID:23649840 | miconazole | increases expression | ISO | Narf (Mus musculus) | 6480464 | Miconazole results in increased expression of NARF mRNA | CTD | PMID:27462272 | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of NARF mRNA | CTD | PMID:28801915 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of NARF mRNA | CTD | PMID:25729387 | paracetamol | affects expression | ISO | Narf (Mus musculus) | 6480464 | Acetaminophen affects the expression of NARF mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of NARF mRNA | CTD | PMID:33387578 | paracetamol | increases expression | ISO | NARF (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of NARF mRNA | CTD | PMID:22230336 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Narf (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NARF mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of NARF mRNA | CTD | PMID:36331819 | phenobarbital | increases expression | ISO | Narf (Mus musculus) | 6480464 | Phenobarbital results in increased expression of NARF mRNA | CTD | PMID:19270015 | phenobarbital | affects expression | ISO | NARF (Homo sapiens) | 6480464 | Phenobarbital affects the expression of NARF mRNA | CTD | PMID:19159669 | pirinixic acid | decreases expression | ISO | Narf (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of NARF mRNA | CTD | PMID:20813756 and PMID:23811191 | resveratrol | multiple interactions | ISO | NARF (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of NARF mRNA | CTD | PMID:23557933 | selenomethionine | affects expression | ISO | NARF (Homo sapiens) | 6480464 | Selenomethionine affects the expression of NARF mRNA | CTD | PMID:17222674 | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of NARF mRNA | CTD | PMID:30047161 | temozolomide | increases expression | ISO | NARF (Homo sapiens) | 6480464 | Temozolomide results in increased expression of NARF mRNA | CTD | PMID:31758290 | tetrachloromethane | affects expression | ISO | Narf (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of NARF mRNA | CTD | PMID:17484886 | tetrachloromethane | decreases expression | ISO | Narf (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of NARF mRNA | CTD | PMID:31919559 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of NARF mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NARF mRNA] | CTD | PMID:31150632 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of NARF mRNA | CTD | PMID:34492290 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of NARF mRNA | CTD | PMID:25729387 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of NARF mRNA | CTD | PMID:25729387 | triadimefon | decreases expression | EXP | | 6480464 | triadimefon results in decreased expression of NARF mRNA | CTD | PMID:30047161 | trichostatin A | affects expression | ISO | NARF (Homo sapiens) | 6480464 | trichostatin A affects the expression of NARF mRNA | CTD | PMID:28542535 | tungsten | decreases expression | ISO | Narf (Mus musculus) | 6480464 | Tungsten results in decreased expression of NARF mRNA | CTD | PMID:30912803 | urethane | increases expression | ISO | NARF (Homo sapiens) | 6480464 | Urethane results in increased expression of NARF mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | Narf (Mus musculus) | 6480464 | Valproic Acid results in increased expression of NARF mRNA | CTD | PMID:21427059 | valproic acid | affects expression | ISO | NARF (Homo sapiens) | 6480464 | Valproic Acid affects the expression of NARF mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | NARF (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of NARF mRNA | CTD | PMID:23179753 | valproic acid | increases expression | ISO | NARF (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of NARF mRNA | CTD | PMID:29154799 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of NARF mRNA | CTD | PMID:23869203 | zinc atom | increases expression | ISO | NARF (Homo sapiens) | 6480464 | Zinc deficiency results in increased expression of NARF mRNA | CTD | PMID:22171008 | zinc(0) | increases expression | ISO | NARF (Homo sapiens) | 6480464 | Zinc deficiency results in increased expression of NARF mRNA | CTD | PMID:22171008 | |